pPLUS® AAV-RC Range
pPLUS® AAV-RC range is a set of ready-to-use RepCap plasmids for AAV production of various serotypes through triple transfection. Optimized for use w...
NEW
Summary
Meet our team at NETIB 2023 to explore our products and services
Our team
Polyplus, part of Sartorius, is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale.
An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services for viral and non-viral delivery. Custom plasmid vector design and plasmid and protein manufacturing was integrated into the offer in 2022 to expand the products and services portfolio to help the industry optimize process economics while meeting strict scientific and regulatory standards.
NEW
Protein Manufacturing Service
Our fully integrated protein manufacturing services covers all needs from initial process development to manufacturing at research, HQ and GMP grade.
NEW
Easy Plasmid Service
Explore our easy plasmid services starting at just $249. Our fully sequenced plasmids, ready for your research, include a miniprep. Reduce project cos...
NEW
pPLUS® AAV-Helper
pPLUS® AAV-Helper is a novel helper plasmid designed for AAV production. This plasmid has been optimized for triple transfection of HEK293 cells in s...
Viral vector DOE Service
Polyplus® free of charge viral vector DOE service is the combination of our expertise in the field of nucleic acid delivery and in DoE methodology.
Plasmid Manufacturing Service
Polyplus offers a comprehensive range of plasmid manufacturing services from DNA plasmid design to plasmid DNA manufacturing and analytical testing.
Whole Plasmid Sequencing Service
Obtain accurate and reliable full length plasmid sequencing with our Next Generation Sequencing service.
Plasmid Engineering Service
Polyplus provides an integrated service for design and production of tailor-made DNA plasmid through our unique and Innovative assembly technology.
NEW
FectoVIR®-LV
FectoVIR®-LV transfection reagent designed to improve Lentiviral vector (LV) titers in HEK-293 suspension cell systems.
NEW
LipidBrick® Library
LipidBrick® is a novel range of proprietary cationic lipids dedicated to the formulation of LNPs for the development of mRNA-based vaccines and thera...
NEW
in vivo-jetRNA®+
in vivo-jetRNA®+ is a ready-to-use transfection reagent composed of lipid-based nanoparticles specifically developed for in vivo mRNA delivery.
FectoVIR®-AAV
Available at research and GMP grade to intensify production of recombinant AAV rAAV viral vectors at any scale from benchtop to 2000L scale bioreactor...
in vivo-jetPEI®
in vivo-jetPEI® is a ready-to-use cationic polymer reagent recommended for in vivo transfection of DNA, siRNA, miRNA, shRNA and other oligonucleotide...
jetOPTIMUS®
jetOPTIMUS® is an innovative cationic nanotechnology developed to improve DNA transfection efficiency in hard-to-transfect cells.
FectoCHO® Expression System
FectoCHO® expression system is optimized for culture and transient protein expression of all CHO cells.
PEIpro®
PEIpro® is the leading PEI-based DNA transfection reagent that offers flexibility and scalability for viral vector manufacturing.
jetMESSENGER®
jetMESSENGER® is a designed for high mRNA transfection efficiency in primary cells, cancer cell lines, neurons, and stem cells.
jetPEI®
High-throughput cDNA libraries screening is a valuable tool to study gene expression and regulation and protein interactions and functions.
FectoPRO®
FectoPRO is a transfection reagent specifically optimized for transient protein and antibody expression in CHO and HEK293 cells.
PULSin®
The delivery of protein and antibody using PULSin® represents a powerful approach for functional studies in live cells.
INTERFERin®
INTERFERin® provides very high silencing efficiency already at 1 nM siRNA and can be used in a wide variety of adherent and suspension cells....
Discover Our Applications
Cell & Gene Therapy
Success of Gene and Cell Therapies is dependent on efficient production of viral vectors that require optimized transfection reagents and viral vector engineering
RNA/DNA Therapeutics
RNA/DNA in vivo delivery is the most powerful alternative to viral vectors for nucleic acid-based therapies. They offer substantial advantages in terms of reliability,safety and costs for nucleic-acid based therapies
Protein Production
Broad range of solutions is needed for manufacturing of functional proteins or antibodies at the desired scale in bacteria, yeast and mammalian cell expression systems
Life Sciences
Optimised plasmid engineering and specific transfection reagents are key to enable protein expression in a wide range of adherent and suspension mammalian cell types